HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kao Q1

This article was originally published in The Rose Sheet

Executive Summary

Consumer product sales in North America and Europe grew 6% to $233.4 mil. (¥1=$.009) largely on sales of John Frieda Brilliant Brunette launch, Japanese firm states in first quarter (ended June 30) sales and earnings release July 22. Brilliant Brunette launched in January (1"The Rose Sheet" Jan. 5, 2004, p. 4). Worldwide consumer products sales were up 6% to $1.5 bil. Excluding negative currency translation due to depreciation of the yen, consumer sales would have been up 7.2%, firm notes. Net sales advanced 6.5% to $2.06 bil., while net income increased 12.6% to $155 mil. Kao recently announced the appointment of Motoki Ozaki to post of president and CEO, replacing former head Takuya Goto...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012319

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel